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a b s t r a c t
We present a mathematical analysis of the transmission of certain diseases using a sto-
chastic susceptible-exposed-infectious-treated-recovered (SEITR) model with multiple
stages of infection and treatment and explore the effects of treatments and external
ﬂuctuations in the transmission, treatment and recovery rates. We assume external ﬂuc-
tuations are caused by variability in the number of contacts between infected and sus-
ceptible individuals. It is shown that the expected number of secondary infections
produced (in the absence of noise) reduces as treatment is introduced into the population.
By deﬁning RT;n and R T ;n as the basic deterministic and stochastic reproduction numbers,
respectively, in stage n of infection and treatment, we show mathematically that as the
intensity of the noise in the transmission, treatment and recovery rates increases, the
number of secondary cases of infection increases. The global stability of the disease-free
and endemic equilibrium for the deterministic and stochastic SEITR models is also pre-
sented. The work presented is demonstrated using parameter values relevant to the
transmission dynamics of Inﬂuenza in the United States from October 1, 2018 through May
4, 2019 inﬂuenza seasons.
© 2019 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi
Communications Co., Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Numerous mathematical models have been developed to study the transmission dynamics of emerging and re-emerging
diseases (Diekmann, Heesterbeek, & Metz, 1990; Driessche & Watmough, 2002; Etbaigha, Willms, & Poljak, 2018; Feng,
Towers, & Yang, 2011; Hollingsworth, Anderson, & Fraser, 2008; Huo, Chen, & Wang, 2016; Korobeinikov, 2009; LaSalle,
1976; Li, Xiao, Zhang, & Yang, 2012; Melesse & Gumel, 2010; Mendez, Campos, & Horsthemke, 2012; Tornatore,
Buccellato, & Vetro, 2005; Otunuga, 2017; Otunuga, 2018; West, Bulsara, Lindenberg, Seshadri, & Shuler, 1979; Yang &
Mao, 2013, Mummert & Otunuga, 2019).Without treatment of such diseases, infection advances in stages and infected in-
dividuals typically die within certain years. Several authors (Birrell, Presanis, & De Angelis, 2012; Hollingsworth et al., 2008;
Korobeinikov, 2009;Melesse&Gumel, 2010; Otunuga, 2018) have studied extensively epidemicmodels with various stages of
infection. Inﬂuenza has various stages of infection ranging from the contagious stage before any symptoms appear (period
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when the ﬂu virus is entering and multiplying in only a few cells in the respiratory tract) to the stage when the ﬂu virus has
proliferated enough for the immune system to notice. The general incubation period for Inﬂuenza (typically known as the ﬂu)
varies for different individuals, usually between one to four days with average incubation period of about two days. This
suggests that it is important to study the different stages of ﬂu infection while studying transmission of infectious diseases.
Although it might be impossible to avoid certain infectious diseases, there are different strategies available that protect
individuals from infection and treat disease once it has developed. It is of high importance to study how such disease reacts to
treatments, and the analysis of treatment stages and treatment effects on infected individuals should be included in models
describing the transmission dynamics of treatable diseases. Several programs such as the Biomedical Advanced Research and
Development Authority have been developed by the U.S. Department of Health and Human Services to provide an integrated,
systematic approach to the development and purchase of vaccines, drugs, therapies, and diagnostic tools necessary for public
health medical emergencies.1
According to the work of Hu et al. (Hu, Nigmatulina, & Eckhoff, 2013), contact rates and patterns among individuals in a
geographic area drive transmission of directly-transmitted pathogens,making it essential to understand and estimate contacts
for simulation of disease dynamics. In their work, Grassly et al. (Grassly& Fraser, 2006) explains different causes of seasonality
in infectious diseases of humans. Theygive different representations of the transmission rate based on the causes of seasonality
in the infectious diseases. In this work, we study the global dynamics of a deterministic and stochastic SEITR epidemic model
with multiple stages of infection and treatments. We assume the population is completely susceptible at the beginning of the
epidemics and derive themeasure of the power of an infectious disease to attack a completely susceptible population using the
deterministicmodel. In the absence of noise, we comparemathematically the expected number of secondary cases of infection
in the presence and absence of treatments and show that the number decreases as the treatment rate increases. We study the
case where the transmission, treatments and recovery rates are assumed to be inﬂuenced by external ﬂuctuations caused by
variability in the number of contacts between infected and susceptible individuals due to weather patterns, school terms, etc.
We assume ﬂuctuations in the treatment rates may be caused by limited availability of drugs or effect of seasonality and this
may result in ﬂuctuations in the recovery rates. Such random variations can be modeled by a Gaussian white noise process
causing the rate to ﬂuctuate around amean value. The external noise is able tomodify the dynamical behavior of themodel by
transforming the deterministic SEITR epidemic model to a stochastic epidemic model. We derive the basic reproduction
number in the presence of noise and analyze how the presence of noise in the transmission, treatments and recovery rates
affects the number of infections produced by an infected individual. The paper is organized as follows. In Section 2, we
formulate the deterministic model describing the transmission and spread of certain diseases, as well as its treatments and
recovery. In Section 3, the existence of equilibrium points, and derivation of reproduction number using next generation
method in thepresenceandabsenceof treatments are analyzed.Analysis of theeffectof treatments andeffectofdroppingoutof
treatment on the number of infection produced by an infected individual are investigated analytically and numerically in
Section 4. The local and global stability of the disease-free and endemic equilibriums are discussed in Section 5. By introducing
noise in the transmission, treatment and recovery rates, we formulate and derive a stochastic model analogous to the deter-
ministicmodel in Section 6. The effects of noise on the transmission, treatment and recovery rates, togetherwith the existence
and stability of the disease-free equilibrium point in the presence of noise are investigated analytically and numerically.
2. Deterministic model formulation
By assuming the human population is completely susceptible at the beginning of an epidemics and sub-dividing the total
population, NðtÞ, into susceptible humans SðtÞ, exposed humans EðtÞ, infected untreated IjðtÞ humans in stage j of infection,
infected humans under treatment and in stage j of infection TjðtÞ, and the recovered population RðtÞ, at time t, we investigate
the transmission and treatment of certain infectious diseases. We assume the total human population NðtÞ satisﬁes NðtÞ ¼
SðtÞ þ EðtÞ þPn
j¼1
ðIjðtÞþTjðtÞÞ þ RðtÞ and humans are recruited into the susceptible population at a rate L. The general popu-
lation is reduced by natural death at a rate m. The population of susceptible humans is reduced by infection due to contact with
infectious (untreated or treated) individual at a full rate b
Pn
j¼1
hjIj. It is well known (Godoy et al., 2018) that inﬂuenza vacci-
nation may not prevent infection but reduces the severity of the disease. The Center for Disease and Control 2 claimed that in
randomized clinical trials, there was evidence that some inﬂuenza viruses developed resistance or reduced susceptibility to
one or more inﬂuenza antiviral CDC recommended FDA-approved drugs like oseltamivir (Tamiﬂu), zanamivir (Relenza),
peramivir (Rapivab), and baloxavir (Xoﬂuza) drugs2. Several authors (Feng et al., 2011; Gani et al., 2005; Kretzschmar, Schim
van der Loeff, Birrell, Angelis, & Coutinho, 2013; Liu and Zhang, 2011; Otunuga, 2018; Qiu & Feng, 2010) have considered
introducing parameter that accounts for the reduction in infectiousness due to treatments among individuals in their model.
In our model, we let εj be the reduced infectiousness due to treatment in stage j of infection and include the reduced rate b
Pn
j¼1
1 Prevention and treatment, https://www.ncbi.nlm.nih.gov/books/NBK209704/, accessed 5.12.2019.
2 https://www.cdc.gov/ﬂu/treatment/baloxavir-marboxil.htm. Page last reviewed: November 18, 2019.
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εjTj due to treatment. Infected (but not yet infectious) individuals become untreated infectious individuals in stage 1 of
infection at a rate p. Untreated infected individuals in stage k of infection migrate into stage kþ 1 of untreated infection at a
rate rk and die of infection at a rate dk. These individuals receive treatment (and migrate to stage k of treated infected
compartment) at a rate tk. Treated infected individuals in stage k of infection migrate to stage kþ 1 of treated infection at a
rate gk and die of infection at a rate dk. Individuals that stop receiving treatment migrate to stage k of untreated infected
compartment at a rate 4k. Untreated and treated infected individuals in stage k of infection recover and migrate to the
recovered compartment at a rate of jk and hk, respectively. The schematics describing the transmission described above is
given in Fig. 1.
The deterministic model governing S, E, Ik, Tk, R for k ¼ 1;2;…;n, is described as follows:
dS ¼

L bSPn
j¼1

hjIj þ εjTj
 mSdt; Sðt0Þ ¼ S0;
dE ¼

bS
Pn
j¼1

hjIj þ εjTj
 ðmþ pÞE dt; Eðt0Þ ¼ E0;
dI1 ¼ ðpE  ðmþ d1 þ r1 þ t1 þ j1ÞI1 þ 41T1Þ dt; I1ðt0Þ ¼ I01;
dIk ¼ ðrk1Ik1  ðmþ dk þ rk þ tk þ jkÞIk þ 4kTkÞ dt; Ikðt0Þ ¼ I0k; k ¼ 2;3;…;n;
dT1 ¼ ðt1I1  ðmþ d1 þ g1 þ 41 þ h1ÞT1Þdt; T1ðt0Þ ¼ T01;
dTk ¼ ðtkIk þ gk1Tk1  ðmþ dk þ gk þ 4k þ hkÞTkÞ dt; Tkðt0Þ ¼ T0k; k ¼ 2;3;…;n;
dR ¼
 Pn
j¼1

jjIj þ hjTj
 mRdt; Rðt0Þ ¼ R0;
(2.1)
Fig. 1. Schematic diagram for the SEITR model. The circle compartments represent group of individuals.
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where the parameters in themodel are described in Table 2, with gn ¼ rn ¼ 0. Since the limit limt/∞supNðtÞ  L=m, we consider
the solution of the model (2.1) in the feasible region
T : ¼
n
ðS; E; I1;…; In; T1;…; Tn;RÞT2R2nþ3þ : 0 Sþ Eþ
Xn
j¼1

Ijþ Tj
þR¼NL
m
o
; (2.2)
where Rþ denotes set of nonnegative real numbers. For the rest of this work, we deﬁne k ¼ L=m. It can be shown that T is
positively invariant with respect to (2.1). We set the sizes of S, E, Ik, Tk, R, for k ¼ 1;2;…;n as percentages by setting L ¼ m.
3. Existence of equilibrium points in the presence and absence of treatments
We discuss the existence and stability of the equilibrium points of (2.1) in the presence and absence of treatment. Under
certain conditions (which are discussed in (3.14) and Section 5), system (2.1) has two unique equilibrium points namely, the
disease-free (denoted P0) and endemic (denoted P1) equilibrium points described as
P0 ¼

S
0
E
0
I
0
1 … I
0
n T
0
1 … T
0
n R
0
u
;
P1 ¼ ð S* E* I*1 … I
*
n T
*
1 … T
*
n R
* Þu:
(3.1)
The equilibrium points P0 and P1 are derived in Subsections 3.1 and 3.2, respectively.
3.1. Disease-free equilibrium P0
The disease-free equilibrium P0 of (2.1) has entries
S
0¼ k; E0 ¼ 0; I0j ¼ 0; T
0
j ¼ 0; R
0 ¼ 0; j ¼ 1;2;…; n: (3.2)
In the following, we derive the measure of the power of an infectious disease to attack a completely susceptible popu-
lation. It is the expected number of secondary cases produced, in a completely susceptible population, by a typical infective
individual. This number, called the basic reproduction number and denoted by RT ;n, is calculated explicitly considering n
stages of infection and treatment. The endemic equilibrium, P1, is expressed in terms of RT ;n. We also discuss a case where no
treatment is received in the population and denote the corresponding reproduction number by R0;n. We show that in order for
the number of infection to diminish to zero on the long run, appropriate parameters in the model must be controlled so that
the number RT ;n is at most one. That is, as long as the number of secondary infection produced by an infected individual is not
more than one, the number of infections diminish to zero on the long run. Above the number RT ;n ¼ 1, disease endemic
presist.
3.1.1. Elimination threshold quantity, RT;n, in the presence of treatments
Deﬁne8><>>:
ak ¼ mþ dk þ rk þ tk þ jk;
bk ¼ mþ dk þ gk þ 4k þ hk;
c ¼ mþ p;
k ¼ L=m:
(3.3)
In the presence of treatments, we write (2.1) in the form
dx¼ðF ðxÞV ðxÞÞ dt; (3.4)
using the next-generation matrix (Driessche & Watmough, 2002), where.
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x ¼
0BBBBBBBBBBBB@
E
I1
«
In
T1
«
Tn
R
S
1CCCCCCCCCCCCA
;F ¼
0BBBBBB@
bS
Xn
j¼1

hjIj þ εjTj

0
«
0
0
1CCCCCCCCA
2nþ31
;V ¼
0BBBBBBBBBBBBBBBBBB@
cE
a1I1  41T1  pE
a2I2  r1I1  42T2
«
anIn  rn1In1  4nTn
b1T1  t1I1
b2T2  t2I2  g1T1
«
bnTn  tnIn  gn1Tn1
mR
Xn
j¼1

jjIj þ hjTj

bS
Xn
j¼1

hjIj þ εjTj
þ mSL
1CCCCCCCCCCCCCCCCCCCCCA
:
The derivatives D F ðP0Þ ¼
 
vF i
vxj
!
¼

Fn 02nþ12
022nþ1 022

and D V ðP0Þ ¼

vV i
vxj
 ¼ Vn 02nþ12J3 J4

of F and V ,
respectively, are evaluated at P0 and partitioned so that Fn ¼ bk
0BB@
0 h1 h2 … hn ε1 ε2 … εn
0 0 0 … 0 0 0 … 0
0 « « 1 « « « 1 «
0 0 0 … 0 0 0 … 0
1CCA
2nþ12nþ1
,
Vn ¼
0@ c 01n 01ns MI I 4
0n1 I t MT
1A, s ¼ ðp 0 … 0 ÞTn1, J3 ¼ 0 j1 j2 … jn h1 h2 … hn0 bkh1 bkh2 … bkhn bkε1 bkε2 … bkεn

,
J4 ¼

m 0
0 m

, and
MI ¼
0BBBBBB@
a1 0 0 0 … 0
r1 a2 0 0 … 0
0 r2 a3 0 … 0
« « « 1 1 «
« « « « 1 «
0 0 … 0 rn1 an
1CCCCCCA; MT ¼
0BBBBBB@
b1 0 0 0 … 0
g1 b2 0 0 … 0
0 g2 b3 0 … 0
« « « 1 1 «
« « « « 1 «
0 0 … 0 gn1 bn
1CCCCCCA;
I 4 ¼ diagð41;42;/;4nÞ; I t ¼ diagðt1; t2;/; tnÞ:
(3.5)
The spectral radius of the matrix FnV1n is given by
RT;n¼ kb
p
c
Xn
k¼1
"
ukhk þ εkvkQk
j¼1

ajbj  tj4j
#; (3.6)
where uk and vk satisfy
uk ¼ bkrk1uk1 þ 4kgk1vk1;
vk ¼ tkrk1uk1 þ akgk1vk1; for k ¼ 1;2;…;n;
(3.7)
and r0 ¼ g0 ¼ 1; u0 ¼ 1; v0 ¼ 0. We note here that ajbj  tj4j ¼ ajbj þ tjbj >0 for j ¼ 1;2;…;n.
Remark 3.1.1. The reproduction number (3.6) can be re-written in matrix form as
RT;n¼ kb
p
c
Xn
k¼1
266664
ð hk εk Þ

bk 4k
tk ak

rk1 0
0 gk1

uk1
vk1

Yk
j¼1
				 bj 4jtj aj
				
377775; (3.8)
where uk1 and vk1 are deﬁned in (3.7) and the matrices

bk 4k
tk ak

and

rk1 0
0 gk1

are coefﬁcient matrices of the
differential equation
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d

Ik
Tk

¼
ak fk
tk bk

Ik
Tk

þ

rk1 0
0 gk1

Ik1
Tk1

¼ 
				 bk fktk ak
				 bk fktk ak
1 Ik
Tk

þ

gk1 0
0 rk1

Ik1
Tk1

;
governing Ik and Tk in (2.1) for k ¼ 2;3;/;n.
Remark 3.1.2. Description of the derivation of RT ;n
For amodel with one stage of infection, if i; j ¼ 1;2;3 represent compartments E; I1 and T1, respectively, then the ði; jÞ entry
of the inverse V11 of the matrix V1 deﬁned in (3.5), and obtained as
V11 ¼
0BBBBBB@
1=c 0 0
p
c
b1
a1b1  t141
b1
a1b1  t141
41
a1b1  t141
p
c
t1
a1b1  t141
t1
a1b1  t141
a1
a1b1  t141
1CCCCCCA; (3.9)
is the average time an individual introduced into compartment j spent in compartment i. It follows directly from (3.9) that the
average time an individual introduced into the exposed compartment spent in the untreated infected compartment I1 is
p
c
b1
a1b1t141 ¼
1
a1
p
c
P∞
j¼0

t1
a1
41
b1
j
, while the average time an individual introduced into the exposed compartment spent in the
treated infected compartment T1 is pc
t1
a1b1t141 ¼
1
b1
p
c
P∞
j¼1

t1
a1
j
41
b1
j1
. An infected individual in the untreated and treated
infected compartments Ij and Tj produces new infection in the exposed compartment E at a rate bhj and bεj, respectively. Thus,
the number RT ;1 ¼ bkh1pc b1a1b1t141 þ bkε1
p
c
t1
a1b1t141 is the expected number of secondary cases produced, in a completely
susceptible population, by a typical infective individual in compartment 1. In general, the average time an individual intro-
duced into the exposed compartment spent in the untreated infected compartment Ik is pc
ukYk
j¼1
ðajbj  tj4jÞ
, while the average
time an individual introduced into the exposed compartment spent in the treated infected compartment Tk is
p
c
vkYk
j¼1
ðajbj  tj4jÞ
. Hence, RT ;n ¼ bk pc
Pn
k¼1
266664 ukhkþεkvkYk
j¼1
ðajbj  tj4jÞ
377775.
Remark 3.1.3. Reproduction number R0;n in the absence of treatment
Deﬁne
ak ¼ mþ dk þ rk þ jk;
bk ¼ mþ dk þ gk þ hk:
(3.10)
In the absence of treatment (that is, tk ¼ 0 for k ¼ 1;2;…;n;) we have uk ¼
Qk
j¼1ðbjrj1Þ, vk ¼ 0 for k ¼ 1;2;…;n; and the
reproduction number RT ;n simpliﬁes to the treatment free reproduction number R0;n given by
R0;n¼ kb
p
c
Xn
k¼1
"
hk
Yk
j¼1
 
rj1
aj
!#
: (3.11)
This is the reproduction number associated with the model without treatment
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dS ¼

L bSPn
j¼1

hjIj
 mSdt;
dE ¼

bS
Pn
j¼1

hjIj
 ðpþ mÞE dt
dI1 ¼ ðpE  ðmþ d1 þ r1 þ j1ÞI1Þ dt;
dIk ¼ ðrk1Ik1  ðmþ dk þ rk þ jkÞIkÞ dt; k ¼ 2;3;…;n
dR ¼
Pn
j¼1
jjIj  m R

dt:
(3.12)
In a completely susceptible population receiving no treatment, we describe the quantity R0;n as the expected number of
secondary infection produced by a typical untreated infected individual in a completely susceptible population.
The disease-free equilibrium point of (3.12) reduces to
~P0¼

~S
0 ~E
0 ~I
0
1 …
~I
0
n
~R
0
u
; (3.13)
3.2. Endemic equilibrium point, P1, in the presence of treatment
The endemic equilibrium P1 ¼

S

E

I

1 … I

n T

1 … T

n R
 u of system (2.1) described in (3.1) is obtained as8>>>>>>>>>>>>>>>>>>>>>>>><>>>>>>>>>>>>>>>>>>>>>>>>:
S
 ¼ k
RT;n
;
E
 ¼ L
c

1 1
RT;n

I

k ¼
p
c
L ukYk
j¼1

ajbj  tj4j


1 1
RT;n

;
T

k ¼
p
c
L vkYk
j¼1

ajbj  tj4j


1 1
RT;n

; k ¼ 1;2;…;n;
R
 ¼ L
m
p
c
Xn
k¼1
0BBBB@ ukjk þ vkhkYk
j¼1

ajbj  t4

1CCCCA

1 1
RT;n

;
(3.14)
provided RT ;n >1, where uk and vk are deﬁned in (3.7).
Remark 3.2.1. Endemic equilibrium in the absence of treatment.
In the absence of treatment, the endemic equilibrium P1 reduces to
~P1¼

~S
 ~E
 ~I

1 …
~I

n
~R
 u
; (3.15)
where ~P1 is derived from (3.14) by setting tk ¼ 0 and obtained as
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8>>>>>>>>>>><>>>>>>>>>>>:
~S
 ¼ k
R0;n
;
~E
 ¼ L
c

1 1
R0;n

;
~I

k ¼
p
c
L
"Yk
j¼1
 
rj1
aj
!#
1 1
R0;n

;
~R
 ¼ L
m
p
c
Xn
k¼1
 
jk
Yk
j¼1
 
rj1
aj
!!
1 1
R0;n

:
(3.16)
provided R0;n >1.
4. Effect of treatment and dropping out treatment in the system
In this section, we study how receiving treatment and dropping out of treatment affect the system.
4.1. Effect of treatment of infection in the system
Consider the reproduction number RT ;j corresponding tomodel (2.1) with j stage(s) of infection (derived by setting n ¼ j in
(3.6)). Write RT ;jðtiÞ≡RT ;j as a function of ti for 1  i; j  n. We deﬁne the quantities RT ;jðti/∞Þ≡ limti/∞RT;jðtiÞ and RT ;jðti ¼ 0Þ≡
RT ;jðtiÞjti¼0 as the expected number of secondary infection produced by a typical infected individual (in a completely sus-
ceptible populationwith j  n stages of infection) as treatment capacity ti goes to inﬁnity and as no treatment is administered
in stage i of infection, respectively.
We can show, after rigorous calculations, that
8>>>>>>>>>>>>>>>>><>>>>>>>>>>>>>>>>>:
8>>>>>><>>>>>>:
RT ;jðt1/∞Þ ¼ kb
p
cb1
Xj
k¼1
bukhk þ bvkεkYk
r¼1
rs1
ðarbr þ brtrÞ
;
bu1 ¼ 0; bv1 ¼ 1; and buk;bvk; ks1 are defined in ð4:3Þ8>>>>>>><>>>>>>:
RT ;jðti/∞Þ ¼ RT;i1 þ kb
p
cbi
ðui1ri1 þ vi1gi1Þ
Xj
k¼i
bukhk þ bvkεkYk
r¼1
rsi
ðarbr þ brtrÞ
; for 2  i  j  n;
bui ¼ 0; bvi ¼ 1; and buk;bvk; ksi are defined in ð4:3Þ
(4.1)
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8>>>>>>>>>>>>>>>>><>>>>>>>>>>>>>>>>>:
8>>>>>>><>>>>>>:
RT;jðt1 ¼ 0Þ ¼ kb
p
ca1
Xj
k¼1
ukhk þ vkεkYk
r¼1
rs1
ðarbr þ brtrÞ
;
u1 ¼ 1; v1 ¼ 0; and uk;vk; ks1 are defined in ð4:3Þ8>>>>>><>>>>>>>:
RT;jðti ¼ 0Þ ¼ RT;i1 þ kb
p
caibi
Xj
k¼i
ukhk þ vkεkYk
r¼1
rsi
ðarbr þ brtrÞ
; for 2  i  j  n;
ui ¼ biri1ui1 þ 4igi1vi1; vi ¼ aigi1vi1; and uk;vk; ksi are defined in ð4:3Þ;
(4.2)
where ui, vi are deﬁned in (3.7) for i ¼ 1;2;/;n, u0 ¼ 1, v0 ¼ 0, and8><>>:
 buk ¼ bkrk1buk1 þ 4kgk1bvk1;bvk ¼ tkrk1buk1 þ akgk1bvk1; for k ¼ iþ 1;/; n; 1  i  n
uk ¼ bkrk1uk1 þ 4kgk1vk1;
vk ¼ tkrk1uk1 þ akgk1vk1; for ksi:
(4.3)
Furthermore,8>>><>>>:
dRT ;j
dti
¼ aibibi
ðaibi þ bitiÞ2

RT ;jðti/∞Þ  RT;jðti ¼ 0Þ

;
d2RT;j
dt2i
¼  2aib
2
i bi
ðaibi þ bitiÞ3

RT;jðti/∞Þ  RT;jðti ¼ 0Þ

; for 1  i; j  n:
(4.4)
It follows from (4.4) that the derivative dRT;jðtiÞdti <0 and the graph of RT ;jðtiÞ concaves up for all ti  0 if and only if
RT ;jðti/∞Þ<RT ;jðti ¼ 0Þ;for 1  i  j  n. Likewise, dRT ;jdti >0 and the graph of RT ;jðtiÞ concaves down for all ti  0 if and only if
RT ;jðti/∞Þ>RT ;jðti ¼ 0Þ;for 1  i  j  n. By deﬁnition, we expect RT ;jðti/∞Þ<RT ;jðti ¼ 0Þ;for 1  i;j  n. This shows that
in a population with j stages of infection, the number of secondary infection, RT ;j, produced by an infected individual in a
completely susceptible population decreases as the treatment rate ti increases.
4.1.1. Case where ti≡t for all i ¼ 1;2;/;n
Deﬁne
R∞;n¼ kb pc
Xn
k¼1
"
εk
Yk
j¼1
 
gj1
bj
!#
; (4.5)
where bj is deﬁned in (3.10). For ﬁxed tj ¼ t, j ¼ 1;2;/;n, we write RT ;n≡RT ;nðtÞ (deﬁned in (3.6)) as a function of t. The
number of secondary infection, RT ;nðtÞ, has the property:
RT;n/R∞;n as t/∞:
The function
f ðtÞ¼RT;nðtÞ
R0;n
; (4.6)
is a rational function of t referred to as the relative elimination threshold. The graph of the function has y-intercept f ð0Þ ¼ 1
(following directly from Remark 3.1.1) and negative zeros. The vertical asymptotes are the negative vertical lines t ¼  ajbj
bj
,
for j ¼ 1;2;/;n . Deﬁne
O.M. Otunuga, M.O. Ogunsolu / Infectious Disease Modelling 5 (2020) 61e90 69
f ¼ 1
R0;n
kb
p
c
Xn
k¼1
"
εk
Yk
j¼1
 
gj1
bj
!#
¼
Pn
k¼1
"
εk
Yk
j¼1
 
gj1
bj
!35
Pn
k¼1
"
hk
Yk
j¼1
 
rj1
aj
!35: (4.7)
The function f ðtÞ/f as t/∞. The value f is the horizontal asymptote of f ðtÞ. It measures the infection transmission
potential when treatment capacity goes to inﬁnity relative to the transmission potential when no treatment is administered.
It follows from property of rational functions that f R0;n <RT ;nðtÞ  R0;n ðthat is;R∞;n <RT ;n R0;nÞ if f <1 and R0;n 
RT ;nðtÞ< f R0;n if f >1. This is represented in Fig. 2 below.
Fig. 2 (a) and (b) show the trajectory of f ðtÞ for the cases where f <1 and f >1 , respectively.
Remark 4.1.1. The quantity R∞;n can be described as the expected number of secondary infection produced by a typical
infected individual as the treatment capacity goes to inﬁnity. From the description of R0;n in Remark 3.1.1, we expect R∞;n ¼
kb pc
Pn
k¼1
"
εk
Qk
j¼1
 
gj1
bj
!#
< kb pc
Pn
k¼1
"
hk
Qk
j¼1
 
rj1
aj
!#
¼ R0;n, that is, we expect the expected number of secondary infection
produced when the treatment capacity goes to inﬁnity to be smaller than the expected number of secondary infection
produced when no treatment is administered. This implies f <1, so that RT ;n <R0;n. This shows that as the treatment rate
increases, the expected number of infection decreases. The highest expected number of infection produced by an infected
individual in a completely susceptible population is R0;n (which is attained when t ¼ 0) while the lowest expected number of
infection is R∞;n (attained as t/∞).
4.2. Effect of dropping out of treatment
Write RT ;jð4iÞ≡RT ;j as a function of 4i for 1  i; j  n. Using similar deﬁnition in Subsection 4.1, we deﬁne the quantities
RT ;jð4i/∞Þ and RT ;jð4i¼ 0Þ as the expected number of secondary infection produced by a typical infected individual (in a
completely susceptible population with j  n stages of infection) as drop out treatment rate 4i goes to inﬁnity and as no one
drops out of treatment in stage i of infection, respectively.
We obtain, after rigorous calculations
8>>>>>>>>>>>>>>>>><>>>>>>>>>>>>>>>>>:
8>>>>>><>>>>>>:
RT ;jð41/∞Þ ¼ kb
p
ca1
Xj
k¼1
ukhk þ vkεkYk
r¼1
rs1
ðarbr þ ar4rÞ
;
u1 ¼ 1; v1 ¼ 0; and uk;vk; ks1 are defined in ð4:10Þ;8>>>>>><>>>>>>>:
RT ;jð4i/∞Þ ¼ RT;i1 þ kb
p
cai
ðui1ri1 þ vi1gi1Þ
Xj
k¼i
ukhk þ vkεkYk
r¼1
rsi
ðarbr þ ar4rÞ
; for 2  i  j  n;
ui ¼ 1;vi ¼ 0; and uk;vk; ksi are defined in ð4:10Þ;
(4.8)
Fig. 2. Graphs of f ðtÞ against t for the cases where f <1 and f >1.
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8>>>>>>>>>>>>>>>>><>>>>>>>>>>>>>>>>>:
8>>>>>>><>>>>>>:
RT;jð41 ¼ 0Þ ¼ kb
p
ca1b1
Xj
k¼1
€ukhk þ €vkεkYk
r¼1
rs1
ðarbr þ ar4rÞ
;
€u1 ¼ b1; €v1 ¼ t1; and €uk;€vk; ks1 are defined in ð4:10Þ;8>>>>>><>>>>>>:
RT;jð4i ¼ 0Þ ¼ RT ;i1 þ kb
p
caibi
Xj
k¼i
€ukhk þ €vkεkYk
r¼1
rsi
ðarbr þ ar4rÞ
; for 2  i  j  n;
€ui ¼ biri1€ui1; €v€i ¼ tiri1€ui1 þ aigi1€v€i1; and €uk; €v€k; ksi are defined in ð4:10Þ;
(4.9)
where ui, vi are deﬁned in (3.7) for i ¼ 1;2;/;n, €u0 ¼ 1, €v0 ¼ 0, and8><>:

uk ¼ bkrk1uk1 þ 4kgk1vk1;
vk ¼ tkrk1uk1 þ akgk1vk1; for k ¼ iþ 1;/;n; 1  i  n
€uk ¼ bkrk1€uk1 þ 4kgk1€vk1;
€vk ¼ tkrk1€uk1 þ akgk1€vk1; for ksi:
(4.10)
Furthermore,8>>>><>>>:
dRT ;j
d4i
¼ aiaibi
ðaibi þ ai4iÞ2

RT;jð4i/∞Þ  RT;jð4i ¼ 0Þ

;
d2RT;j
d42i
¼  2aia
2
i bi
ðaibi þ ai4iÞ3

RT ;jð4i/∞Þ  RT;jð4i ¼ 0Þ

; for 1  i; j  n:
(4.11)
It follows from (4.11) that the derivative dRT;jð4iÞd4i >0 and the graph of RT ;jð4iÞ concaves down for all 4i  0 if and only if
RT ;jð4i/∞Þ>RT ;jð4i ¼ 0Þ; for 1  i  j  n. Likewise, dRT;jd4i <0 and the graph of RT ;jð4iÞ concaves up for all 4i  0 if and only if
RT ;jð4i/∞Þ<RT ;jð4i ¼ 0Þ; for 1  i  j  n. By deﬁnition, we expect RT ;jð4i/∞Þ>RT ;jð4i ¼ 0Þ; for 1  i  j  n. This shows
that in a populationwith j stages of infection, the number of secondary infection, RT ;j, produced by an infected individual in a
completely susceptible population increases as the treatment dropout rate 4i increases.
4.2.1. Case where 4i≡4 for all i ¼ 1;2;/;n
Assume 4j≡4 for j ¼ 1;2;/;n, and write RT ;n≡RT ;nð4Þ. We see that
RT;nð4Þ/R0;n; as 4/∞;
and
RT;nð4¼0Þ¼ kb
p
c
X
k¼1
n
"Y
j¼1
k
 
rj1
aj
!
hkþ
vkQ
j¼1
k 
ajbj
εk
#
;
where vk is deﬁned in (3.7) for k ¼ 1;2;/;n. The vertical asymptotes of the rational function RT ;nð4Þ are the negative vertical
lines 4 ¼  ajbj=aj, for j ¼ 1;2;/;n. Since RT ;nð4Þ is a rational function of 4whose numerator and denominator have the same
degree, it follows that RT ;nð4Þ is an increasing function of 4 if and only if RT ;nð4 ¼ 0Þ  RT ;nð4/∞Þ ¼ R0;n, for 4  0. By
deﬁnition, we expect RT ;nð4 ¼ 0Þ  RT ;nð4/∞Þ. This shows that as the rate of dropping out of treatment increases, the
expected number of secondary infection produced by an infected individual increases to R0;n.
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4.2.2. Numerical results verifying the effects of treatment and dropping out of treatment on the number of infections
Here, we use relevant parameters to the transmission dynamics of inﬂuenza disease in the United States for the numerical
simulations of the reproduction number as a function of the treatment and dropout rates. We set the life expectancy of the
United States population to 80 years3 and the total population to be 329;256;465 as of July 2018.4 Using the parameters
collected from the Center for Disease Control and Prevention (CDC), the time from when a person is exposed and infected
with ﬂu to when symptoms begin is about 2 days, but can range from about 1 to 4 days5 and uncomplicated inﬂuenza signs
and symptoms typically resolve after 3e7 days for the majority of people.6 Antiviral drugs, when used for treatment, can
reduce symptoms and shorten sick time by 1 or 2 days6.
CDC7 estimates that, fromOctober 1, 2018, throughMay 4, 2019, there have been 37:4 42:9million ﬂu illness, 17:3 20:1
million ﬂu medical visits, 531 647 thousand ﬂu hospitalizations and 36:4 61:2 thousand ﬂu death. We deﬁne εj as a
reduction factor in infectiousness (in stage j of infection) due to ﬂu treatment and it reduces the infectious period to 1hj <
1
jj
. For
more information about the parameter εj, we refer readers to the work of Lipsitch et al. (Liu & Zhang, 2011), Feng et al. (Feng
et al., 2011), Kretzschmar et al. (Kretzschmar et al., 2013) and CDC2. In their work, Lipsitch (Liu and Zhang, 2011) introduced a
parameter which is the reduction in hazard of infection for an individual on prophylaxis. They claimed with probability ep,
transmission is blocked and of those blocked infections, a proportion ap are only partially blocked. Using two infectious
stages, we set 1r1 ¼ 4,
1
r2
¼ 3, 1g1 ¼ 4,
1
g2
¼ 2, b ¼ 0:8, h1 ¼ 0:5, h2 ¼ 0:106, ε1 ¼ 0:2, ε2 ¼ 0:05, t1 ¼ 0:08, t2 ¼ 0:12, 41 ¼ 1= 3,
42 ¼ 1=4, j1 ¼ 1=5, j2 ¼ 1=10, h1 ¼ 1=4, h2 ¼ 1=8, d1 ¼ 1:43 104, d2 ¼ 1:1 104, d1 ¼ 0:925 104, d2 ¼ 0:8 104.
The value 20:1329:27 for the number
Pn
j¼1
Tjð0Þ of individuals under treatment is close to the number reported by Biggerstaff et al.
(Biggerstaff, Jhung, Kamimoto, Balluz, & Finelli, 2012). According to the paper published by Tokars at al. (Tokars, Olsen, &
Reed, 2018), between 3% and 11:3% of the U.S. population gets infected and develops ﬂu symptoms each year. The value
37:4
329:27 is approximately in this reported range. See Tables 1, 2 and 3 for parameter values and descriptions.
Fig. 3 (a) shows the graph of RT ;1≡RT ;1ðtÞ against t≡t1. Fig. 3 (b) shows the graph of RT ;2≡RT ;2ðtÞ against t≡ t1 ¼ t2. The
graphs show that with no treatment, the reproduction number is R0;n, and as more treatment is introduced into the popu-
lation the number of secondary infection RT ;n reduces until it approaches R∞;n, which is the least number of secondary
infection that can be produced by an infected individuals when introduced into susceptible population. This is explained in
Subsection 4.1.
Fig. 4 (a) shows the graph of RT ;1≡RT ;1ð4Þ against 4≡41. Fig. 4 (b) shows the graph of RT ;2≡RT ;2ð4Þ against 4≡ 41 ¼ 42. The
graphs show that the number of secondary infection RT ;n increases to R0;n as individuals drop out of treatment. This is
explained in Subsection 4.2.
Fig. 5 (a) shows the graph of RT ;1≡RT ;1ðt;4Þ against t≡t1 and 4≡41. Fig. 5 (b) shows the graph of RT ;2ðt;4Þ against t≡ t1 ¼
t2 and 4≡41 ¼ 42.
5. Existence and stability of equilibrium points
In this section, we discuss the endpoint behavior of the solution of (2.1). We give conditions under which the solution
converges on the long run to the disease-free or endemic equilibrium.
5.1. Existence and stability of disease-free equilibrium P0 in the presence of treatment
The following theorems show the condition for the local and global stability of the disease-free equilibrium, P0. We study
condition(s) under which disease elimination exists on the long run. The idea presented here is similar to thework in Otunuga
(Otunuga, 2018). To analyze the local asymptotic stability of P0, we linearize (2.1) about P0 and show that the real part of all
eigenvalues of the coefﬁcient matrix of the linear associated system is negative.
DeﬁneJ ¼ ð S k E I1…In T1…Tn R Þu. The linearization of (2.1) along the disease-free equilibrium P0 is obtained as
dJ¼AJ dt; Jðt0Þ¼J0; (5.1)
3 https://www.cia.gov/library/publications/the-world-factbook/rankorder/2102rank.html.
4 https://www.cia.gov/library/publications/the-world-factbook/geos/us.html.
5 https://www.cdc.gov/ﬂu/about/keyfacts.htm. Page last reviewed: August 27, 2018.
6 https://www.cdc.gov/ﬂu/professionals/acip/clinical.htm. Page last reviewed: March 8, 2019
7 https://www.cdc.gov/ﬂu/about/burden/preliminary-in-season-estimates.htm. Page last reviewed: May 9, 2019
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where A ¼
0BB@
A1;1 A1;2 A1;3 A1;4
A2;1 A2;2 A2;3 A2;4
A3;1 A3;2 A3;3 A3;4
A4;1 A4;2 A4;3 A4;4
1CCA with A1;1 ¼ m 00 c

, A1;2 ¼ bk
h1 h2 … hn
h1 h2 … hn

,
A1;3 ¼ bk
ε1 ε2 … εn
ε1 ε2 … εn

, A1;4 ¼

0
0

, A2;1 ¼

011 p
0n11 0n11

, A2;2 ¼  MI , A2;3 ¼ I 4, A2;4 ¼ A3;4 ¼ ð0n1 Þ,
A3;1 ¼ ð0n2 Þ, A3;2 ¼ I t, A3;3 ¼  MT , A4;1 ¼ ð012 Þ, A4;2 ¼ ðj1 j2/jn Þ, A4;3 ¼ ðh1 h2/hn Þ, A4;4 ¼  d, andMI ;MT ;
I 4;I t are deﬁned in (3.5). We can express the characteristic polynomial of A in the form
detðA rI 2nþ32nþ3Þ¼  ðrþmÞ detðA rI 2nþ22nþ2Þ; (5.2)
where A is the square matrix formed by deleting the ﬁrst row and column of A in (5.1) and r is the eigenvalue of A.
Table 1
Description of variables for the epidemic model.
Variable Description
S Population of susceptible individuals
E Population of exposed individuals
Ik Population of untreated infected individuals in stage k of infection
Tk Population of treated infected individuals in stage k of infection
R Population of individuals who recovered from disease
Table 2
Description of parameters for the epidemic model.
Parameter Description
L Recruitment rate into the population
b Transmission rate of infection
hk Infectivity of untreated individuals in stage k of infection
εk Reduced infectiousness due to treatment in stage k of infection
m Natural death rate
p Infectious rate for exposed individuals
dk Death rate associated with untreated infection in stage k of infection
dk Death rate associated with treated infection in stage k of infection
tk Treatment rate of infected individuals in stage k of infection
4k Rate of dropping out of treatment in stage k
rk Transition rate from stage k to kþ 1 for untreated individuals
gk Transition rate from stage k to kþ 1 for treated individuals
jk Recovery rate for untreated individuals in stage k of infection
hk Recovery rate for treated individuals in stage k of infection
Fig. 3. Effect of treatment on the reproduction number RT ;n for n ¼ 1 and n ¼ 2.
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Theorem 5.1. The real part of all eigenvalues of A is negative if RT ;n <1. One of the eigenvalues of A is zero if RT ;n ¼ 1 and at least
one of the eigenvalues is positive real if RT ;n >1.
Proof. It sufﬁces to show that themaximum real part of all eigenvalues of A, denoted, sðAÞ, is less than zero if RT ;n < 1. To do
this, we use relations D12 and J29 in (Plemmons, 1977) to show that the real part of each eigenvalues of the matrixB ¼  A is
positive. The matrix can be written in the form
B ¼L U ; (5.3)
where L and U are lower and upper diagonal matrices, respectively, with positive diagonals. The matrices L ¼ ðL i;jÞ and
U ¼ ðU i;jÞ are computed rigorously as follows:
L i;j¼
1
D j
										
B 1;1 B 1;2 … B 1;j
B 2;1 B 2;2 … B 2;j
« « … «
B j1;1 B j1;2 … B j1;j
B i;1 B i;2 … B i;j
										
; for i  js1; L i;1 ¼
		B i;1		
D 1
for i ¼ 1; 2;…;2nþ 2; and 0 elsewhere;
Fig. 4. Effect of dropping out of treatment on the reproduction number RT ;n for cases n ¼ 1 and n ¼ 2.
Fig. 5. Effect of treatment and dropping out of treatment on the reproduction number for the cases n ¼ 1 and n ¼ 2, and RT ;n <1.
O.M. Otunuga, M.O. Ogunsolu / Infectious Disease Modelling 5 (2020) 61e9074
U i;j¼
1
D i1
								
B 1;1 … B 1;i1 B 1;j
B 2;1 … B 2;i1 B 2;j
« « « «
B i;1 … B i;i1 B i;j
								; for 1si  j; U 1;j ¼ B 1;j; for j ¼ 1;2;…;2nþ 2; and 0 elsewhere;
where D 0 :¼ 1, and D j ¼
								
B 1;1 B 1;2 … B 1;j
B 2;1 B 2;2 … B 2;j
« « … «
B j;1 B j;2 … B j;j
								 for j ¼ 1;2;…;2nþ 2, and can be simpliﬁed as
a0 ¼ 1; R0;0 ¼ 0;
R0;j ¼ kb
p
c
Xj
k¼1


hk
Yk
r¼1

rr1
ar

; j ¼ 1;2;/;nþ 1
RT ;j ¼ RT;j þ kb
p
c
ujYj
k¼1
ðakbk  tk4kÞ
Xn
k¼jþ1


hk
Yk
r¼jþ1

rr1
ar

; j ¼ 1;2;/;n 1
D j ¼ c
hQj1
k¼0ak
i
1 R0;j1

; for j ¼ 1;2;/;nþ 1;
D nþ1þj ¼ c
hQj
k¼1ðakbk  tk4kÞ
iYn
k¼jþ1ak

1 RT;j

; for j ¼ 1;2;/;n 1;
D 2nþ1 ¼ c
Qn
k¼1ðakbk  tk4kÞ
i
1 RT ;n

;
D 2nþ2 ¼ c m
Qn
k¼1ðakbk  tk4kÞ
i
1 RT ;n

;
(5.4)
where j:j is the determinant operator, fak; bkg and { RT ;n;uk} are deﬁned in (3.3) and (3.6), respectively. Since uk > uj
Qk
r¼jþ1
ðbrrr1Þ and
Qk
r¼jþ1ðarbrÞ>
Qk
r¼jþ1ðarbr tr4rÞ for k ¼ jþ 1; /; n, it follows that
kb pc
ujYj
k¼1
ðakbk  tk4kÞ
Pn
k¼jþ1


hk
Qk
r¼jþ1

rr1
ar

¼ kb pc
Pn
k¼jþ1
266664
hkuj
Yk
r¼jþ1
ðbrrr1Þ
Yj
r¼1
ðarbr  tr4rÞ
Yk
r¼jþ1
ðarbrÞ
377775< kb pc P
n
k¼jþ1
26664 hkukYk
r¼1
ðarbr  tr4rÞ
37775 and so
RT ;j <RT ;n for j ¼ 1;2;/;n 1. Therefore, if RT ;n <1, it follows from (5.4) that R0;j1 <RT ;n for j ¼ 1;2;/;nþ 1,D j > 0 and the
diagonal entries U j;j ¼ D jD j1 >0 for j ¼ 1;2; /; 2nþ 2. Since B2Z2nþ2 is a Z-matrix
ðthat is; bi;j 0 if isj;1 i; j 2nþ2; whereB ¼ ðbi;jÞÞ and the diagonal entries L j;j ¼ D jD j ¼ 1 for j ¼ 1;2;…; 2nþ 2, it
follows from relations D12 and J29 in (Plemmons, 1977) that the real part of each eigenvalues of matrixB is positive, which is
in turn equivalent to sðAÞ<0. The determinant of the matrix A is D2nþ2, which is the product of all 2nþ 2-eigenvalues of A. If
RT ;n ¼ 1, then D2nþ2 ¼ 0, which means at least one of the eigenvalues of A is zero. If RT ;n >1, then D2nþ2 <0, which means at
least one of the eigenvalues of A is positive.-
Theorem 5.2. The disease-free equilibrium P0 of (2.1) is locally asymptotically stable if RT ;n <1 and unstable if RT ;n > 1.
Proof. The proof follows from (5.2) and Theorem 5.1.-
The above theorem shows that if RT ;n <1, the system ðS; E; I1;/; In; T1;/; Tn;RÞ approaches the equilibrium point P0
whenever it starts somewhere near it in T . The local stability of the disease-free equilibrium ~P0 of system (3.12) without
treatment follows immediately from Theorem 5.2 by setting tk ¼ 0 for all k ¼ 1;2;/;n. We state the theorem belowwithout
proof.
Corollary 5.3. The disease-free equilibrium ~P0 of (3.12) is locally asymptotically stable if R0;n <1 and unstable if R0;n > 1.
The following theorem gives the threshold under which disease elimination (considered independent of the initial
conditions in T ) exists.
Theorem 5.4. The disease-free equilibrium P0 of (2.1) is globally stable in the feasible region T if RT ;n  1.
Proof. Deﬁne the Lyapunov function L : Rþ2nþ2/R
þ by
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LðS; E; I1; I2;…; In; T1;…; TnÞ¼

S S0 S0 ln S
S
0

þ6Eþ
Xn
k¼1
bfkIk þXn
k¼1
bqkTk; (5.5)
where Rþ is the set of positive real numbers, 6, bfk and bqk satisfy
6 ¼ 1; bfnbqn
!
¼ bS
0
anbn  tn4n
 
hnbn þ tnεn
hn4n þ anεn
!
;
 bfnkbqnk
!
¼ 1
ankbnk  tnk4nk
" 
bnkrnk gnktnk
4nkrnk gnkank
! bfnkþ1bqnkþ1
!
þ bS0
 
hnkbnk þ tnkεnk
hnk4nk þ ankεnk
!#
;
for k ¼ 1;2; 3;…;n 1; (5.6)
and ð bf1 bq1 Þu reduces to bf1bq1

¼ c
p

RT;n
RT;n

;
where
RT;n¼ kb
p
c
Xn
k¼1
266664 hkuk þ εkvkYk
j¼1

ajbj  tj4j

377775; (5.7)
and uk and vk are recurssive sequences deﬁned by8<:u1 ¼ 41; v1 ¼ a1;uk ¼ bkrk1uk1 þ 4kgk1vk1;
vk ¼ tkrk1uk1 þ akgk1vk1; for k ¼ 2; 3; :::;n:
The coefﬁcients 6, bfk and bqk satisfy bfkak bfkþ1rk bS0hk tkbqk ¼ 0, bqkbk  bqkþ1gk  bS0εk  4kbfk ¼ 0 for k ¼ 1;2;…;
n 1, bfnan  tnbqn  bS0hn ¼ 0 and bqnbn 4nbfn bS0εn ¼ 0. It follows from (5.5) and (5.6) that the derivative of L computed
along solution of (2.1) is
dL
dt
¼LþmS0LS0

SmSð16ÞbS
X
k¼1
n
ðhkIkþ εTkÞ ð6c bf1pÞE X
k¼1
n1bfkak bfkþ1rk bS0hk tkbqkIk

X
k¼1
n1bqkbk bqkþ1gk bS0εk4kbfkTkbfnanbS0hn tnbqnIn  bqnbnbS0εn4nbfnTn:
If RT ;n  1, then ð6c  bf1pÞ  0. Thus, it follows from (5.6) and (5.7) that bfk and bqk are positive for k ¼ 1;2;/;n and
dL
dt
 L
 
S
0
S
þ S
S
02
!
 0
using the fact that S
0 ¼ k ¼ L=m and 1 ¼
 
S
0
S
S
S
0
!1=2
 12
 
S
0
S þ SS0
!
. If RT ;n <1, then dL=dt ¼ 0 if and only if S ¼ S0, E ¼ 0, Ik ¼ 0
and Tk ¼ 0 for all k ¼ 1;2;…;n. Substituting this into the equation for dR=dt in (2.1) shows that R/0 as t/∞. If RT ;n ¼ 1, then
dL=dt ¼ 0 if and only if S ¼ S0. The largest invariant set of (2.1) contained in fðS; E; I1;…; In; T1;…; Tn;RÞu2T : dL =dt¼ 0g is
the set fP0g. The global stability of P0 follows from the LaSalle invariance principle (LaSalle, 1976).-
The above theorem shows that disease can be eliminated on the long run from the population if parameters are controlled
so that the elimination threshold RT ;n is at most 1. This elimination is independent of the initial number of infection. The
global stability of the disease-free equilibrium ~P1 of system (3.12) without treatment follows immediately from Theorem 5.4
by setting tk ¼ 0 for all k ¼ 1;2;/;n. We state the theorem below without proof.
Corollary 5.5. The disease-free equilibrium ~P0 of (3.12) is globally asymptotically stable in the feasible region T if R0;n  1.
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5.1.1. Numerical results verifying global stability of disease-free equilibrium P0
Here, we use relevant parameters (given in Table 3) to the transmission dynamics of inﬂuenza disease in the United States
for the numerical simulations of the number of susceptible, untreated infected, treated infected and recovered individuals
satisfying the SEITR models (2.1) and (3.12).
Fig. 6 (a) shows the comparison of the trajectories of the number (in percentages) of exposed (En), untreated infected (I1n)
population in stage 1 of infection for model (3.12) (no treatment) with the trajectories of the number of exposed (E), untreated
infected (I1) and treated infected (T1) population in stage 1 of infection for model (2.1) (with treatment) for the case where
n ¼ 1. Fig. 6 (b) shows the comparison of the trajectories of the number of exposed (En), untreated infected (I1n) and (I2n)
population in stages 1 and 2 of infection, respectively, for model (3.12) with the trajectories of the number of exposed (E),
untreated infected (I1), (I2) and treated infected (T1), (T2) populations in stages 1 and 2 of infection, respectively, for model
(2.1) with the case n ¼ 2. It is clear from the graph that the introduction of treatment in the system reduces the number of
exposed and infected individuals (that is, E< En, I1 < I1n and I2 < I2n) after some days. The number of exposed and infected
individuals tends to zero on the long run and the number of susceptible individuals tends to 1. In this case, R01 ¼ 0:8885,
R02 ¼ 0:9971, RT1 ¼ 0:8337. and RT2 ¼ 0:9255. The graph of the solution ðSðtÞ; EðtÞ; I1ðtÞ;/; InðtÞ;RðtÞÞ of system (3.12)
converges to ~P0 as t/∞. This conﬁrms Corollary 5.5. Likewise, the graph of the solution
ðSðtÞ; EðtÞ; I1ðtÞ;/; InðtÞ; T1ðtÞ;/; TnðtÞ;RðtÞÞ of system (2.1) converges to P0 as t/∞. This conﬁrms Theorem 5.4.
5.2. Existence and stability of endemic equilibrium P1 in the presence of treatment
Theorem 5.6. The endemic equilibrium P1 (given in (3.14)) of (2.1) exists if and only if RT ;n >1 and does not exist if RT ;n < 1. It
becomes disease-free (that is, P1 ¼ P0) if RT ;n ¼ 1.
Proof. It follows directly from (3.14) that S

>0, E

>0, I

k >0, T

k >0 and R

>0 for k ¼ 1;2;…;n, if RT ;n >1. The result for the
case where RT ;n  1 follows from (3.14).-
Table 3
Parameter values for the epidemic model: Case study Inﬂuenza.
Parameter Description Default Value References
L Recruitment rate into the population 1
80 365day
1 CIA3
b Transmission rate of infection Pn
j¼1
bhj ¼ 0:5 Feng et al. (2011)
hk Infectivity of untreated individuals in stage k of infection 0.5 (Feng et al., 2011; Roosa & Chowell, 2019)
εk Reduced infectiousness due to treatment in stage k of
infection
0.2
Feng et al. (2011)
p Infectious rate for exposed individuals 1
p
¼ 2 (days) CDC
5
m Natural death rate L CIA3
dk Death rate associated with untreated infection 1:43 104 Murphy, Xu, Kochanek, and Arias (2018)
dk Death rate associated with treated infection Assumed
tk Treatment rate of individuals in stage k of infection Pn
j¼1
tj2½0:05;0:2
(day1)
CDC6
4k Rate of dropping out of treatment in stage k Pn
j¼1
1
4j
¼ 7 (days) Assumed
rk Average duration of untreated infection Pn
j¼1
1
rj
2½3; 7 (days) CDC
6
gk Average duration of treated infection Pn
j¼1
1
gj
2½1; 6 (days) CDC
6
jk Recovery rate for untreated individuals in stage k of infection Pn
j¼1
1
jj
2½3;15 (days) (Feng et al., 2011; Roosa & Chowell, 2019)&
Assumed
hk Recovery rate for treated individuals in stage k of infection Pn
j¼1
1
hj
2½2;14 (days) (Feng et al., 2011; Roosa & Chowell, 2019)&
Assumed
Sð0Þ Initial susceptible Population Assumed
Eð0Þ Initial Exposed Population AssumedPn
j¼1
Ijð0Þ
Initial Untreated Infected Population 37:4
329:27
CIA3, CDC7
Pn
j¼1
Tjð0Þ
Initial Treated Infected Population 20:1
329:27
CIA3, CDC7
Rð0Þ Initial Recovered Population Assumed
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The following theorem gives the threshold for persistence of endemic (considered independent of the initial number of
infection).
Theorem 5.7. The endemic equilibrium P1 of the system (2.1) is globally stable in the feasible region T if RT ;n >1 and fk >0; mk >
0; where fk and mk are given in ð5:11Þ:
Proof. The existence of the endemic equilibrium P1 follows from Theorem 5.6 if RT ;n >1. Assume RT ;n >1. Deﬁne the
Lyapunov function L : Rþ2nþ2/R
þ by
LðS; I1;…; In; T1;…; TnÞ¼

S S  S ln S
S


þ6

E E  E ln E
E


þ
Xn
k¼1
f

k

Ik I

k I

k ln
Ik
I

k

þ
Xn
k¼1
q

k

Tk T

k T

k ln
Tk
T

k

; (5.8)
where 6, fk and q

k, k ¼ 1;2;…;n, are positive constants deﬁned by
6 ¼ 1;0@fn
q

n
1A ¼ bS
anbn  tn4n
 
hnbn þ tnεn
hn4n þ anεn
!
;
0B@f

nk
q

nk
1CA ¼ 1
ankbnk  tnk4nk
264 bnkrnk gnktnk
4nkrnk gnkank
!0B@f

nkþ1
q

nkþ1
1CAþ bS hnkbnk þ tnkεnk
hnk4nk þ ankεnk
!375;
for k ¼ 1;2; 3;…;n 1; (5.9)
and

f

1 q

1
u
reduces to 
f

1
q

1
!
¼ S c
kp

RT;n
RT;n

;
where RT ;n is given in (5.7). It follows from (5.9) and (3.14) that 6c f1p ¼ 0, fkak fkþ1rk bS

hk tkq

k ¼ 0, q

kbk
q

kþ1gk  bS

εk  4kfk ¼ 0 for k ¼ 1;2;…;n 1, fnan  bS

hn  tnqn ¼ 0 and q

nbn bS

εn 4nfn ¼ 0.
The derivative of L computed along solution of (2.1) is
Fig. 6. Graphs of comparison of deterministic trajectories of solution of system (2.1) and (3.12) for the cases where n ¼ 1 and n ¼ 2, respectively.
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dL
dt
¼ LL S

S
 mSþ mS  ð16ÞbS
X
k¼1
n
ðhkIk þ εkTkÞ 

6c f1p

E 
X
k¼1
n1
f

kak  fkþ1rk  bS

hk  tkq

k

Ik

X
k¼1
n1
q

kbk  q

kþ1gk  bS

εk  4kfk

Tk 

f

nan  bS

hn  tnqn

In 

q

nbn  bS

εn  4nfn

Tn  f1pI

1
E
I1

X
k¼1
n 
f

k4kI

k
Tk
Ik
þ qktkT

k
Ik
Tk


X
k¼2
n 
f

krk1I

k
Ik1
Ik
þ qkgk1T

k
Tk1
Tk

6bE
X
k¼1
n 
hk
SIk
E
þ εk
STk
E

;
þ
X
k¼1
n 
f

kakI

k þ q

kbkTk
þ6cE:
Deﬁne
s ¼ S
S
; e ¼
E
E
; ik ¼
Ik
I

k
; and tk ¼
Tk
T

k
for k ¼ 1;2;…;n;
C¼LþmS þ
X
k¼1
n 
f

kakI

kþ q

kbkTk
þ6cE:
We have
dL
dt
¼ C  L
s
 mS*s ð16*ÞbS*s
Xn
k¼1

hkI
*
kik þ εkT
*
ktk
 6*c f*1pE*e

Xn1
k¼1

f
*
kak  f*kþ1rk  bS
*
hk  tkq
*
k

I
*
kik 
Xn1
k¼1

q
*
kbk  q
*
kþ1gk  bS
*
εk  4kf*k

T
*
ktk 

f
*
nan  bS
*
hn  tnq*n

I
*
nin
q*nbn  bS*εn  4nf*nT*ntn  f*1pE* ei1 X
n
k¼1

f
*
k4kT
*
k
tk
ik
þ q*ktkI
*
k
ik
tk


Xn
k¼2

f
*
krk1I
*
k1
ik1
ik
þ q*kgk1T
*
k1
tk1
tk

6*bS*
Xn
k¼1

hkI
*
k
sik
e
þ εkT
*
k
stk
e

;
¼ z

sþ 1
s
 2


Xn
k¼2
gk
0@1
s
þ sik
e
þ e
i1
þ
Xk
j¼2
ij1
ij
 ðkþ 2Þ
1A g11s þ si1e þ ei1  3


Xn
k¼2
fk
0@1
s
þ stk
e
þ e
i1
þ
Xk
j¼2
ij1
ij
þ ik
tk
 ðkþ 3Þ
1A f11s þ st1e þ ei1 þ i1t1  4


Xn
k¼1
dk

ik
tk
þ tk
ik
 2


Xn
k¼2
mk
0@1
s
þ stk
e
þ e
i1
þ
Xk
j¼2
tj1
tj
þ i1
t1
 ðkþ 3Þ
1A;
(5.10)
where
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z ¼ mS*;
dk ¼ 4*kfkT
*
k; for k ¼ 1;2; :::;n;
gk ¼ 6*bS
*
hkI
*
k; for k ¼ 1;2; :::;n;
mk ¼ q
*
kgk1T
*
k1  q
*
kþ1gkT
*
k; for k ¼ 2;3;/;n 1;
mn ¼ q*ngn1T
*
n1;
f1 ¼ 6*bS*ε1T*1;
fk ¼ q
*
ktkI
*
k  dk >0; for k ¼ 2;3;/; n;
C ¼ 2zþ
Xn
k¼1
ðð2þ kÞgk þ ð3þ kÞfk þ 2dkÞ þ
Xn
k¼2
ð3þ kÞmk:
(5.11)
hence, from (5.10)e(5.11) and the fact that the arithmetic mean of a list of non-negative real numbers is greater than or equal
to the geometric mean of the same list (Steele, 2004), it follows that 1 ¼

s 1s
1
2
 12

s þ 1s

; 1 ¼

1
s
si1
e
e
i1
1
3
 13

1
s þ si1e þ ei1

;
1 ¼

1
s
st1
e
e
i1
i1
t1
1
4
 14

1
s þ st1e þ ei1 þ
i1
t1

; 1 ¼
 
1
s
sik
e
e
i1
Qk
j¼2
ij1
ij
! 1
kþ2
 1kþ2
 
1
s þ sike þ ei1 þ
Pk
j¼2
ij1
ij
!
;
1 ¼
 
1
s
stk
e
e
i1
ik
tk
Qk
j¼2
ij1
ij
! 1
kþ3
 1kþ3
 
1
s þ stke þ ei1 þ
ik
tk
þ Pk
j¼2
ij1
ij
!
; 1 ¼
 
1
s
stk
e
e
i1
i1
t1
Qk
j¼2
tj1
tj
! 1
kþ3
 1kþ3
 
1
sþstke þei1 þ
i1
t1
þPk
j¼2
tj1
tj
!
for
k ¼ 2;…;n, and 1 ¼

ik
tk
tk
ik
1
2
 12

ik
tk
þ tkik

, for k ¼ 1;2;…;n, and
dL
dt
 0:
Equality holds if and only if S ¼ S, E=E ¼ Ij1=I

j1 ¼ Ij=I

j ¼ Tj1=T

j1 ¼ Tj=T

j ¼ 1 for j ¼ 2;3;…;n. Using (3.14) and the
fact that RðtÞ satisﬁes (2.1), it follows that RðtÞ/R as t/∞. The largest invariant set of (2.1) contained in
fðS; E; I1;…; In; T1;…; Tn;RÞu2T : dL =dt¼ 0g is the singleton fP1g. By the LaSalle’s Invariance Principle (LaSalle, 1976), it
follows that P1 is globally stable in the feasible region if RT ;n >1 .-
Fig. 7. Graphs of comparison of deterministic trajectories of solution of system (2.1) and (3.12) for the cases where n ¼ 1 and n ¼ 2, with RT ;n > 1.
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The global stability of the endemic equilibrium ~P1 of system (3.12) without treatment follows immediately from Theorem
5.7 by setting tk ¼ 0 for all k ¼ 1;2;/;n. We state the theorem below without proof.
Corollary 5.8. The endemic equilibrium ~P1 (given in (3.16)) of (3.12) is globally asymptotically stable if R0;n >1.
5.2.1. Numerical results verifying the global stability of P1 and effect of treatment
Using two infectious stages, we use the same values of parameters given in Table 3 except that we set b ¼ 0:5; h1 ¼ 1:5;
h2 ¼ 0:5; ε1 ¼ 0:5; ε2 ¼ 0:01; m ¼ 0:0125: .
Fig. 7 (a) shows the comparison of the trajectories of the number of exposed (En), untreated infected (I1n) individuals for
model (3.12) with trajectories of the number of exposed (E), untreated infected (I1) and treated infected (T1) individuals for
model (2.1) for the case where n ¼ 1 and RT ;1 >1. Fig. 7 (b) shows the comparison of the trajectories of the number of exposed
(En), untreated infected (I1n), (I2n) individuals for model (3.12) with trajectories of the number of exposed (E), untreated
infected (I1), (I2), and treated infected (T1), (T2) individuals for model (2.1) for the case where n ¼ 2 and RT ;2 > 1. It is clear
from the graph that the introduction of treatment in the system reduces the number of exposed and infected individuals (that
is, E< En, I1 < I1n and I2 < I2n) after some days. In this case, R01 ¼ 1:7397, R02 ¼ 1:9549, RT1 ¼ 1:5934. and RT2 ¼ 1:7665. The
endemic equilibrium point for system (3.12) is (S
 ¼ 0:5748;E ¼ 0:0104; I1 ¼ 0:0112;R
 ¼ 0:1475) for the case n ¼ 1 and
(S
 ¼ 0:5115; E ¼ 0:0119; I1 ¼ 0:0129; I

2 ¼ 0:0053; R
 ¼ 0:1983) for the case n ¼ 2. Likewise, the endemic equilibrium
points for system (2.1) for cases n ¼ 1 and n ¼ 2 are (S ¼ 0:6276;E ¼ 0:0091; I1 ¼ 0:0087;T1 ¼ 0:0010;R
 ¼ 0:1594) and
(S
 ¼ 0:5661;E ¼ 0:0106;I1 ¼ 0:0101;I

2 ¼ 0:0037;T

1 ¼ 0:0012;T

2 ¼ 0:000842;R
 ¼ 0:2240), respectively. The graph of the
solution ðSðtÞ; EðtÞ; I1ðtÞ;/; InðtÞ;RðtÞÞ of system (3.12) converges to ~P1 as t/∞. This conﬁrms Corollary 5.8. Likewise, the
graph of the solution ðSðtÞ; EðtÞ; I1ðtÞ;/; InðtÞ; T1ðtÞ;/; TnðtÞ;RðtÞÞ of system (2.1) converges to P1 as t/∞. This conﬁrms
Theorem 5.7.
Fig. 8 (a) shows the graph of RT ;1≡RT ;1ðt;4Þ against t≡t1 and 4≡41. Fig. 8 (b) shows the graph of RT ;2ðt;4Þ against t≡ t1 ¼
t2 and 4≡41 ¼ 42. The graphs show that for ﬁxed 4, as more (less) treatment is introduced into the population, the number of
secondary infection RT ;n reduces (increases) until it approaches R∞;n (R0;n), which is the least (highest) number of secondary
infection that can be produced by an infected individuals when introduced into susceptible population. This is explained in
Subsection 4.1. Also, the number of secondary infection RT ;n increases to R0;n as individuals drop out of treatment. This is
explained in Subsections 4.1 and 4.2.
6. Derivation of stochastic model: effect of ﬂuctuations and stability of disease-free equilibrium
In this section, we study the effect of noise on the transmission rates and infectivities, fbhk;bεkg; the treatment rates ftkg;
the recovery rates fjkg and fhkg in stage k of untreated and treated individuals, respectively, for k ¼ 1;2;/;n. We assume the
noise/external ﬂuctiations in the system is caused by variability in the number of contacts between infected and susceptible
individuals and such randomvariations can be modeled by a Gaussianwhite noise (Mendez et al., 2012). We also assume that
ﬂuctuations in the treatment rates may be caused by limited availability of drugs or effect of seasonality. This, in turn, causes
Fig. 8. Effect of treatment and dropping out of treatment on the reproduction number for the cases n ¼ 1 and n ¼ 2, with RT ;n >1.
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ﬂuctuations in the recovery rates. By allowing these rates to ﬂuctuate about a mean value, we introduce external ﬂuctuations
in the model as follows:8>><>:
b ≡ bþ b C ðtÞ;
tk ≡ tk þ tkW kðtÞ;
jk ≡ jk þ jkZ kðtÞ;
hk ≡ hk þ hkZ kðtÞ; for k ¼ 1;2;/; n;
(6.1)
whereC k;W k;Z k and Z k are independent Gaussian noise terms with zero mean, and b>0, tk >0, jk >0 and hk > 0 are the
noise intensities, a measure of the amplitude of ﬂuctuations, for k ¼ 1;2;/; n. By substituting (6.1) into (2.1), we get a
Langevin equation. The resulting equation is a stochastic differential equation. It is important to be able to interprete and
evaluate the noise structure of this equation. The Ito^ approach on stochastic differential equation depends on Markovian and
Martingale properties. These properties do not obey the traditional chain rule. Whereas, the Stratonovich approach obeys the
traditional chain rule and allowswhite noise to be treated as a regular derivative of a Brownian orWiener process. It has been
suggested by several authors like West et al., Wong et al. (West et al., 1979; Wong & Zakai, 1965) that Stratonovich calculus is
appropriate for Langevin equations with both internal and external noise. For this reason, by substituting (6.1) into (2.1), we
extend the resulting equation to a Stratonovich stochastic model of the form
dS ¼
0@L bSXn
j¼1

hjIj þ εjTj
 mS
1Adt  SXn
j¼1

sjIj þ sjTj

+dCjðtÞ;
dE ¼
0@bSXn
j¼1

hjIj þ εjTj
 ðpþ mÞE
1Aþ SXn
j¼1

sjIj þ sjTj

+dCjðtÞ;
dI1 ¼ ðpE  ðmþ d1 þ r1 þ t1 þ j1ÞI1 þ 41T1Þ dt  t1I1+dW1ðtÞ  j1I1+dZ1ðtÞ;
dIk ¼ ðrk1Ik1  ðmþ dk þ rk þ tk þ jkÞIk þ 4kTkÞ  tkIk+dWkðtÞ  jkIk+dZkðtÞ dt; k ¼ 2;3; :::;n;
dT1 ¼ ðt1I1  ðmþ d1 þ g1 þ 41 þ h1ÞT1Þdt þ t1I1+dW1ðtÞ  h1T1+dZ1ðtÞ;
dTk ¼ ðtkIk þ gk1Tk1  ðmþ dk þ gk þ 4k þ hkÞTkÞ dt þ tkIk+dWkðtÞ  hkTk+dZkðtÞ; k ¼ 2;3; :::;n;
dR ¼
0@Xn
j¼1

jjIj þ hjTj
 mR
1Adt þXn
j¼1
jjIj+dZjðtÞ þ
Xn
j¼1
hjTj+dZjðtÞ;
(6.2)
where + denotes the Stratonovich integral (Arnold, 1974); CðtÞ;WiðtÞ, ZiðtÞ, ZiðtÞ, i ¼ 1;2;…;n, are standardWiener process on
a ﬁltered probability space (U;ðF tÞt0;P); the initial process xðt0Þ ¼ ðSðt0Þ; Eðt0Þ; I1ðt0Þ;…; Inðt0Þ; T1ðt0Þ;…; Tnðt0Þ;Rðt0ÞÞ is F t0
measurable and independent of CðtÞ Cðt0Þ, WiðtÞ Wiðt0Þ, ZiðtÞ  Ziðt0Þ and ZiðtÞ Ziðt0Þ, i ¼ 1;2;…;n.
The Stratonovich dynamic model (6.2) is converted to its Itbo’s equivalent (stated below) using the Stratonovich-Itbo
conversion theorem given in Bernardi et al. (Bernardi, Madday, Blowey, Coleman,& Craig, 2001) and Kloeden et al. (Kloeden&
Platen, 1995).
Theorem 6.1. The Ito^ stochastic differential equation having the same solution as the 2nþ 3-dimensional Stratonovich stochastic
differential equation (6.2) is given by
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dS ¼
0@L bSXn
j¼1

hjIj þ εTj
 mSþ 1
2
S
Xn
j¼1

sjIj þ sjTj
21Adt  SXn
j¼1

sjIj þ sjTj

dCjðtÞ;
dE ¼
0@bSXn
j¼1

hjIj þ εTj
 ðpþ mÞE  1
2
S
Xn
j¼1

sjIj þ sjTj
21Aþ SXn
j¼1

sjIj þ sjTj

dCjðtÞ;
dI1 ¼

pE  a1I1 þ 41T1 þ
1
2

t21 þ j
2
1

I1

dt  t1I1dW1ðtÞ  j1I1dZ1ðtÞ;
dIk ¼

rk1Ik1  akIk þ 4kTk þ
1
2

t2k þ j
2
k

Ik

 tkIkdWkðtÞ  jkIkdZkðtÞ dt; k ¼ 2; 3; :::;n;
dT1 ¼

t1I1  b1T1 þ
1
2

 t21I1 þ h21T1

dt þ t1I1dW1ðtÞ  h1T1dZ1ðtÞ;
dTk ¼

tkIk þ gk1Tk1  bkTk þ
1
2

 t2kIk þ h2kTk

dt þ tkIkdWkðtÞ  hkTkdZkðtÞ; k ¼ 2;3; :::;n;
dR ¼
0@Xn
j¼1

jjIj þ hjTj
 mR 1
2
Xn
j¼1

j
2
j Ij þ h2j Tj
1Adt þXn
j¼1

jjIjdZjðtÞ þ hjTjdZjðtÞ

:
(6.3)
Proof. The proof follows using the Stratonovich-Itbo conversion theorem given in Bernardi et al. (Bernardi et al., 2001) and
Kloeden et al. (Kloeden & Platen, 1995).
Following similar approach presented in Otunuga (Otunuga, 2018), we can show, using the functionVðt;xÞ ¼ lnðS þ E þPn
j¼1
ðIj þ TjÞ þ R þ eLÞ, that LV<V and infjxj>MVðt;xÞ/∞; as M/∞, where L is a differential operator called the L- operator
deﬁned by
LVðt;uÞ¼ vVðt;uÞ
vt
þ vVðt;uÞ
vu
A þ 1
2
trace
"
Bu
v2Vðt;uÞ
vu2
B
#
(6.4)
where vVðt;uÞvu ¼

vVðt;uÞ
vu1
;…; vVðt;uÞvu2nþ3

and v
2Vðt;uÞ
vu2 ¼
 
v2Vðt;uÞ
vuivuj
!
2nþ32nþ3
. It follows from Theorem 3.5 of Khasminskii (Rafail, 2012)
that there exists a solution xðtÞ ¼ ðSðtÞ; EðtÞ; I1ðtÞ;…; InðtÞ; T1ðtÞ;…; TnðtÞ;RðtÞÞ of (6.3) which is an almost surely continuous
stochastic process and is unique up to equivalence if xðt0Þ2T is independent of the processes CiðtÞ Ciðt0Þ, WiðtÞ Wiðt0Þ,
ZiðtÞ Ziðt0Þ, ZiðtÞ Ziðt0Þ, i ¼ 1;2;/;n. The solution described above can be shown to be nonnegative and in the feasible
region T using a similar idea presented in (Yang & Mao, 2013).
6.1. Equilibrium points and basic reproduction number in the presence of noise
The point P0 deﬁned in (3.1)e(3.2) is also the disease-free equilibrium of system (6.3). We calculate an equivalent of RT,n in
(3.6), denoted byR T ;n and derive threshold under which system (6.3) becomes disease-free on the long run.We ﬁrst linearize
the non-linear stochastic system about the disease-free equilibrium and study the stability of the solution of the linear
system.
Deﬁne J ¼ ð S k E I1…In T1…Tn R Þu. The linearization of (6.3) about the disease-free equilibrium P0 results in
dJ¼A J dt þ
Xn
i¼1

GidCiðtÞþGidWiðtÞþHidZiðtÞþHidZiðtÞ

J; (6.5)
where A ¼
0BB@
A 1;1 A 1;2 A 1;3 A 1;4
A 2;1 A 2;2 A 2;3 A 2;4
A 3;1 A 3;2 A 3;3 A 3;4
A 4;1 A 4;2 A 4;3 A 4;4
1CCAwith A 1;1 ¼ A1;1, A 1;2 ¼ A1;2, A 1;3 ¼ A1;3, A 1;4 ¼ A1;4, A 2;1 ¼ A2;1, A 2;3 ¼ A2;3,
A 2;4 ¼ A2;4;A 3;1 ¼ A3;1, A 3;4 ¼ A3;4, A 4;1 ¼ A4;1 and A 4;4 ¼ A4;4 deﬁned in (5.1),
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A 2;2 ¼ 
0BBBBBBBBBBBBBBBBBBBBBB@
a1 
t21 þ j
2
1
2
0 0 0 … 0 0
r1 a2 
t22 þ j
2
2
2
0 0 … 0 0
0 r2 a3 
t23 þ j
2
3
2
0 … 0 0
« « « « 1 « «
0 0 … … … rn1 an 
t2n þ j
2
n
2
1CCCCCCCCCCCCCCCCCCCCCCA
;
A 3;3 ¼ 
0BBBBBBBBBBBBBBBBBBBBBB@
b1 
h21
2
0 0 0 … 0 0
g1 b2 
h22
2
0 0 … 0 0
0 g2 b3 
h23
2
0 … 0 0
« « « « 1 « «
0 0 … … … gn1 bn 
h2n
2
1CCCCCCCCCCCCCCCCCCCCCCA
;
A 3;2 ¼ I t, A 4;2 ¼

j1 
j
2
1
2
j2 
j
2
2
2
/jn 
j
2
n
2

, A 4;3 ¼

h1 
h21
2
h2 
h22
2
/hn 
h2n
2

, where.
I
J
¼ diagðJ1;J2;/;JnÞ, I t ¼ diag
 
t1  t
2
1
2 ;t2 
t
2
2
2 ;/;tn 
t
2
n
2
!
, ak and bk are deﬁned in (3.3), Gi, G
i
, Hi and H
i
are 2nþ
3 2nþ 3 matrices with entries Gi1;iþ2 ¼  ksi, Gi1;nþiþ2 ¼  ksi, Gi2;iþ2 ¼ ksi, Gi2;nþiþ2 ¼ ksi, Giiþ2;iþ2 ¼  ti, Ginþiþ2;iþ2 ¼
ti, H
i
iþ2;nþiþ2 ¼  ji, Hi2nþ3;iþ2 ¼ ji, Hinþiþ2;nþiþ2 ¼  hi, Hi2nþ3;nþiþ2 ¼ hi, and zero otherwise for j ¼ 1;2;/; n. Deﬁne
UðtÞ ¼ E½JðtÞ. The function UðtÞ satisﬁes the differential equation
dU¼A U dt: (6.6)
The characteristic polynomial of A can be expressed as
detðA  rI 2nþ32nþ3Þ¼  ðrþmÞ detðA  rI 2n2nÞ; (6.7)
where A is the matrix obtained be deleting the ﬁrst row and column of A in (6.5), and r is the eigenvalue.
Using the idea presented in Mendez et al. (Mendez et al., 2012) and in Section 3.1.1, we calculate the reproduction number
R T ;n with respect to the deterministic model (6.6) in the presence of treatment as
R T;n ¼
kbp
c
Xn
k¼1
266664 ~ukhk þ εk~vkYk
j¼1

~aj
~bj  ~tj4j

377775; (6.8)
where
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~aj ¼ aj 
t2j þ j
2
j
2
;
~bj ¼ bj 
h2j
2
;
~tj ¼ tj 
t2j
2
;
~uk ¼ ~bkrk1~uk1 þ 4kgk1~vk1;
~vk ¼ ~tkrk1~uk1 þ ~akgk1~vk1; for k ¼ 1;/;n;
with ~u0 ¼ 1, ~v0 ¼ 0. We note here that the threshold R T ;n is nonnegative provided
~tj0; ~hj ¼ hj  h2j
.
2  0; ~jj ¼ jj  j
2
j
.
2  0: (6.9)
For the rest of this work, we assume condition (6.9) is satisﬁed.
Remark 6.1.1. We note here that the number R T ;n reduces to RT ;n if tj ¼ jj ¼ hj ¼ 0 for all j ¼ 1;2;/;n.
Remark 6.1.2. Condition (6.9) indicates that the noise intensities tj, jj and hj must not exceed the rates
ﬃﬃﬃﬃﬃﬃﬃ
2tj
q
,
ﬃﬃﬃﬃﬃﬃﬃ
2jj
q
andﬃﬃﬃﬃﬃﬃﬃ
2hj
q
, respectively, for the model to be well deﬁned.
6.2. Effect of noise in the treatment, and recovery rates
In this section, we study the effect of ﬂuctuations in the treatment and recovery rates.
6.2.1. Effect of noise in the treatment rates
Assuming condition (6.9) is satisﬁed, and hj ¼ jj ¼ 0 for j ¼ 1;2;/; n, we wish to study how the number of infection
changes due to changes in the treatment intensity rates ftjg. Deﬁne RT ;n≡RT ;nðtiÞ (given in (3.6)) andR T ;n≡R T ;nðtiÞ. It is easy
to show that RT ;jðti  t2i =2Þ ¼ R T ;jðtiÞ. As discussed in Subsection 4.1, the derivative dRT ;jdti  0 if and only if RT ;jðti/∞Þ 
RT ;jðti ¼ 0Þ; for 1  i  j  n, that is, RT ;jðtiÞ is a decreasing function of ti if and only if RT ;jðti/∞ RT ;jðti ¼ 0Þ;
for 1 i j n. It follows that RT ;jðtiÞ  R T ;jðtiÞ provided RT ;jðti/∞Þ  RT ;jðti ¼ 0Þ; for 1  i  j  n. The same result
follows for the casewhere ti≡t for all i ¼ 1;2;/;n, that is, RT ;nðtÞ  RT ;n

tt22

¼ R T ;nðtÞ provided R∞;n <R0;n. An increase in
the noise intensity in the treatment rate increases the number of secondary infection cases produced by a typical infective
individual.
6.2.2. Effect of noise in the recovery rates of untreated infected individual
Assuming condition (6.9) is satisﬁed, and tj ¼ hj ¼ 0 for j ¼ 1;2;/; n. We wish to study how the number of infection
changes due to changes in the untreated recovery intensity rates fjjg of infected individual. WriteR T ;n≡R T ;nðj1;/;jnÞ as a
function of fjgnj¼1. Since the functions ~gjðtÞ ¼ 1ðajt2=2Þbjtj4j and gjðtÞ ¼
ajt2=2
ðajt2=2Þbjtj4j are increasing function of t for j ¼ 1;2;/;
n, and R T ;nðj1;/;jnÞ can be expressed in terms of ~gjðjjÞ and gjðjjÞ, it follows from the increasing property of gjðjjÞ that
R T ;n≡R T ;nðj1;/;jnÞ  R T ;nð0;0;/;0Þ ¼ RT ;n. The higher the noise intensity in the untreated infected recovery rates, the
higher the number of secondary infection cases produced by a typical infective individual.
6.2.3. Effect of noise in the recovery rates of treated infected individual
Assuming condition (6.9) is satisﬁed and tj ¼ jj ¼ 0 for j ¼ 1;2;/; n. By writing R T ;n≡R T ;nðh1;/; hnÞ as a function of
fhgnj¼1, wewish to show thatR T ;n >R T ;nð0;/;0Þ ¼ RT ;n. Since the functions 1
~aj
 
bj
h2j
2
!
~tj4j
and
 
bi
h
2
j
2
!
 
~aj
 
bj
h2j
2
!
~tj4j
! are increasing
function of hj for j ¼ 1;2;/;n, it follows thatR T ;n≡R T ;nðh1;/;hnÞ  R T ;nð0;/;0Þ ¼ RT ;n, that is, as the noise intensity in the
recovery rate hj of treated infected individuals increases, the number of secondary infection cases produced by a typical
infective individual increases.
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6.2.4. Numerical analysis
We use the parameters presented in Table 3 to verify the results claimed in Subsubsections 6.2.1-6.2.3.
Fig. 9 (a), (b) and (c) show the graphs of R T ;2≡R T ;2ð~tÞ, R T ;2≡R T ;2ð~jÞ and R T ;2≡R T ;2ð~hÞ against ~t (ﬁxing ~j ¼ ~h ¼ 0Þ), ~j
(ﬁxing ~t ¼ ~h ¼ 0Þ) and ~h (ﬁxing ~t ¼ ~j ¼ 0Þ), respectively. Fig. 9 (d) shows the graph of R T ;2≡R T ;2ð~t; ~jÞ against ~t and ~j. The
trajectories of these graphs suggest that the higher the intensity of noise in the treatment rate, recovery rates of untreated and
treated infected individuals, the higher the number of secondary infections produced by an infected individuals when
introduced into a susceptible population.
Fig. 10 (a) and (b) show the graphs ofR T ;2≡R T ;2ð~t; ~hÞ against ~t and ~h andR T ;2≡R T ;2ð~j; ~hÞ against ~j and ~h. The trajectories
of these graphs suggests that the higher the intensity of noise in the treatment rate, recovery rates of untreated and treated
infected individuals, the higher the number of secondary infections produced by an infected individuals when introduced into
a susceptible population.
6.3. Stability of infection-free equilibrium P0 of (6.3)
In this section, we discuss conditions for stability of the infection-free equilibrium P0 of (6.3) in the presence of noise. We
study the conditions for stochastic stability of the disease-free equilibrium P0 of the linear associated system (6.5) and later
use Theorem A.2 in (Tornatore et al., 2005) to extend the result to that of the nonlinear system (6.3).
Theorem 6.2. Assume condition (6.9) is satisﬁed. The real part of all eigenvalues of A is negative if R T ;n <1.
Fig. 9. Effect of noise on treatment rates and recovery rates of untreated and treated infected individuals for the case n ¼ 2.
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Proof. The proof follows from (6.9) and Theorem 5.1 by setting aj≡aj t
2
j þj
2
j
2 , bj≡bj
h2j
2 , tj≡tj
t
2
j
2 , jj≡jj
j
2
j
2 , and hj≡ hj
h2j
2
into matrix A in (5.1).-
Writing the system of non-linear stochastic differential equation (6.3) in terms of J reduces to
dJ1¼
0@bðJ1þkÞXn
j¼1

hjJjþ2þ εjJnþjþ2
m J1þ12ðJ1þkÞXn
j¼1

sjJjþ2þsjJnþjþ2
21A dt
ðJ1þkÞ
Xn
j¼1

sjJjþ2þsjJnþjþ2

dCjðtÞ;
dJ2¼
0@bðJ1þkÞXn
j¼1

hjJjþ2þεjJnþjþ2
 c J212ðJ1þkÞXn
j¼1

sjJjþ2þsjJnþjþ2
21A
þðJ1þkÞ
Xn
j¼1

sjJjþ2þsjJnþjþ2

dCjðtÞ;
dJ3¼

sEJ2a1J3þJ1Jnþ3þ
1
2

t21þj
2
1

J3

dtt1J3dW1ðtÞj1J3dZ1ðtÞ;
dJkþ2¼

rk1Jkþ1akJkþ2þJkJnþkþ2þ
1
2

t2k þj
2
k

Jkþ2

dttkJkþ2dWkðtÞjkJkþ2dZkðtÞ; for;
dJnþ3¼

t1J3b1Jnþ3þ
1
2

t21J3þh21Jnþ3

dtþt1J3dW1

t

h1Jnþ3dZ1

t

dJnþkþ2¼

tkJkþ2þgk1Jnþkþ1bkJnþkþ2þ
1
2

t2kJkþ2þh2kJnþkþ2

dtþtkJkþ2dW1

t

hkJnþkþ2dZk

t

; for;
dJ2nþ3¼
0@Xn
j¼1

jjJjþ2þhjJnþjþ2
mJ2nþ312Xn
j¼1

j
2
j Jjþ2þh2j Jnþjþ2
1A dtþ
Pn
j¼1

jjJjþ2dZjðtÞþhjJnþjþ2dZjðtÞ

;
(6.10)
for k ¼ 2;/;n, where ak and bk are deﬁned in (3.3).
Fig. 10. Effect of noise on treatment rates and recovery rates of untreated and treated infected individuals for the case n ¼ 2.
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Let F and G be the drift and diffusion coefﬁcients of the linear system (6.5), respectively, and f and g the drift and diffusion
coefﬁcients of the non-linear system (6.10), respectively. We give a theorem concerning the global stability of the disease-free
equilibrium point P0 by showing that Theorems A.1 and A.2 of Tornatore et al., (2005) is satisﬁed with respect to systems (6.5)
and (6.10).
Theorem 6.3. The disease-free equilibrium P0 of the system (6.3) is globally asymptotically stable in the feasible region T if
R T ;n <1.
To prove this, we ﬁrst show that if R T ;n <1, the trivial solutionJ ¼ 0 of the linear stochastic differential equation (6.5) is
assymptotically stable and later show that the drift and diffusion coefﬁcients f ðt;JÞ and gðt;JÞ, respectively, of the nonlinear
system (6.10) satisfy the inequality
kf ðt;JÞ  Fðt;JÞk þ kgðt;JÞ  G ðt;JÞk< x kJk (6.11)
in a sufﬁciently small neighbourhood of J ¼ 0, with a sufﬁciently small constant x.
Proof. If R T ;n <1, it follows from Theorem 6.2 that the real part of all eigenvalues of A is negative. Hence, there exist a
diagonal matrix Y (with positive diagonal entries, say, r1; r2;/; r2nþ3 ) and a real number bz >0 such that suðYA þA uYÞs bzsus for every nonzero vector s2R2nþ3 (see relation I25 of (Plemmons, 1977)) . Let J ¼ ðJ1;J2;…;J2nþ3Þu be a vector
satisfying the linear system (6.5) and deﬁne V : ½0; T   R2nþ3/Rþ by
Vðt;JÞ¼JTYJ:
Let bs ¼ max
1jn
fs2j ; s2j ; tj;jj; hjg such that r1 ¼ r2 ¼ bz10k2bs, rjþ2 ¼ rnþjþ2 ¼ r2nþ3 ¼ bz10bs, for j ¼ 1;2;/; n. Using (6.4), the
L-operator deﬁned in (6.4) satisﬁes
LVðt;JÞ ¼ JuðYA þ A uYÞJþJu
X
i¼1
n 
GiuYGi þ GiuYGi þ HiuYHi þ HiuYHi

J
 bzJuJþJuX
i¼1
n 
GiuYGi þ GiuYGi þ HiuYHi þ HiuYHi

J
¼ bz X2nþ3
j¼1
J
2
j þ
Xn
j¼1

ðr1 þ r2Þk2s2j þ

rjþ2 þ rnþjþ2

t2j þ r2nþ3j
2
j

J
2
jþ2
þ
X
j¼1
n 
ðr1 þ r2Þk2s2j þ rjþ2j
2
j þ

r2nþ3 þ rnþjþ2

h2j

J
2
nþjþ2
 bzX
j¼1
2nþ3
J
2
j þ
z
2
X
j¼1
n
J
2
jþ2 þ
bz
2
X
j¼1
n
J
2
nþjþ2 ¼ zJ
2
1  zJ
2
2 
z
2
X
j¼1
n
J
2
jþ2 
bz
2
X
j¼1
n
J
2
nþjþ2 < 
bz
2
J
u
J:
Let rl and ru be minfr1;…; r2nþ3g and maxfr1;…; r2nþ3g, respectively. Then rlkJk2  Vðt;JÞ  rukJk2. It follows from
Theorem A.1 of Tornatore et al., (2005) that the trivial solution J ¼ 0 of (6.5) is asymptotically stable. We deduce from this
result that if the initial condition (in T ) of system (6.5) is near 0, then the solution ðSðtÞ; EðtÞ; I1ðtÞ;/; InðtÞ; T1ðtÞ;/; TnðtÞ;RðtÞÞ
approaches P0 on the long run if R T ;n <1. To prove the global stability of the solution J ¼ 0 of (6.10) (equivalent to the
disease-free equilibrium P0 of (6.3)), we choose x>0 sufﬁciently small in a neighbourhood of J ¼ 0 so that jJj< x and
jf ðt;JÞFðt;JÞj þ jgðt;JÞG ðt;JÞj reduces toﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2

bJ1
X
j¼1
n 
hjJjþ2 þ εjJnþjþ2
 1
2
ðJ1 þ kÞ
X
j¼1
n 
sjJjþ2 þ sjJnþjþ2
2vuut þ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
2J
2
1
X
j¼1
n 
sjJjþ2 þ sjJnþjþ2
2vuut

ﬃﬃﬃ
2
p
0@J21
0@1
2
Xn
j¼1
b

h2j þ ε2j

þ

s2j þ s2j
1Aþ 1
2
ðxþ kÞ
Xn
j¼1

sjJ
2
jþ2 þ sjJ
2
nþjþ2

þ 1
2
ðbþ 1Þ
Xn
j¼1

J
2
jþ2 þJ
2
nþjþ2
1A
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 hjJj;
where h ¼ x
ﬃﬃﬃ
2
p
max
1jn
(
1
2
Pn
i¼1b

h2i þ ε2i

þ

s2j þ s2j

;bþ 1; ðxþ kÞsj; ðxþ kÞsj
)
The global stability result follows from The-
orem A.2 of (Tornatore et al., Vetro).
6.4. Numerical veriﬁcation of global stability of infection-free equilibrium points for the stochastic model
Fig. 11 (a) shows the trajectories of E, I1 and T1 satisfying model (6.3) for the case where n ¼ 1 and R T ;1 <1. Fig. 11 (b)
shows the trajectory of E, I1, I2, T1, T2 satisfying model (6.3) for the case where n ¼ 2 and R T ;2 <1. In this case, R T1 ¼ 0:8056
and R T2 ¼ 0:8908.
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